Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways

Apoptosis: A Review of Programmed Cell Death

Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574

Coronavirus as a possible cause of severe acute respiratory syndrome

Peiris, M. J. S., Lai, S., Poon, L. L. M., Guan, Y., Yam, L., Lim, W., Nicholls, J. M., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,916

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

Assiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W. N., Balkhy, H. H., Al-Hakeem, R. F., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70204-4 · Cited by 1,435

Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

Doitsh, G., Galloway, N. L. K., Geng, X., Yang, Z., Monroe, K. M., Zepeda, O., Hunt, P. W., Hatano, H., Sowinski, S., Muñoz-Arias, I., et al. (2013) · Nature · doi:10.1038/nature12940 · Cited by 1,216

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection

Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., & Yuen, K. Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-07 · Cited by 1,192

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066

Clinical and immunological features of severe and moderate coronavirus disease 2019

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750

Extrapulmonary manifestations of COVID-19

Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185

Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology

Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524

Cytokine release syndrome in severe COVID-19

Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912

Coronaviruses — drug discovery and therapeutic options

Zumla, A. I., Chan, J. F., Azhar, E. I., Hui, D. S. C., & Yuen, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,711

Longitudinal Characteristics of Lymphocyte Responses and Cytokine Profiles in the Peripheral Blood of SARS-CoV-2 Infected Patients

Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102763 · Cited by 1,726

Immunology of COVID-19: Current State of the Science

Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623

The COVID-19 pandemic

Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W.-C., Wang, C.-B., & Bernardini, S. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1783198 · Cited by 1,744

From SARS to MERS, Thrusting Coronaviruses into the Spotlight

Song, Z., Xu, Y., Bao, L., Zhang, L., Yü, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,292

Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up

Wang, L., He, W., Yu, X., Hu, D., Bao, M., Liu, H., Zhou, J., & Jiang, H. X. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.019 · Cited by 1,255

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

Costela-Ruiz, V. J., Montes, R. I., Puerta, J. M., Ruíz, C., & Melguizo‐Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,132

Human Coronavirus: Host-Pathogen Interaction.

Fung, T. S., & Liu, D. X. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115759 · Cited by 907

Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19)

Umakanthan, S., Sahu, P. K., Ranade, A. V., Bukelo, M. M., Rao, J. S., Abrahão‐Machado, L. F., Dahal, S., Kumar, H. D. V., & Kv, D. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138234 · Cited by 791

Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China

Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 699

Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19

Chu, H., Chan, J. F., Wang, Y., Yuen, T. T., Chai, Y., Hou, Y., Shuai, H., Yang, D., Hu, B., Huang, X., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa410 · Cited by 659

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV

Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K., Trilling, M., Lu, M., Dittmer, U., & Yang, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25709 · Cited by 629

COVID-19: Melatonin as a potential adjuvant treatment

Zhang, R., Wang, X., Ni, L., Di, X., Ma, B., Niu, S., Liu, C., & Reiter, R. J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117583 · Cited by 629

The signal pathways and treatment of cytokine storm in COVID-19

Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 618

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

Chan, J. F., Yao, Y., Yeung, M. L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yü, P., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 607

Human Coronaviruses: A Review of Virus–Host Interactions

Lim, Y. X., Ng, Y. W., Tam, J. P., & Liu, D. X. (2016) · Diseases · doi:10.3390/diseases4030026 · Cited by 606

Coagulopathy in COVID‐19

Iba, T., Levy, J. H., Levi, M. M., & Thachil, J. V. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14975 · Cited by 610

IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes

Channappanavar, R., Fehr, A. R., Zheng, J. H., Wohlford-Lenane, C., Abrahante, J. E., Mack, M., Sompallae, R. R., McCray, P. B., Meyerholz, D. K., & Perlman, S. M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126363 · Cited by 556

Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors

Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P., Wang, M., Li, S., Morita, H., Altunbulakli, C., et al. (2020) · Allergy · doi:10.1111/all.14429 · Cited by 555

The molecular virology of coronaviruses

Hartenian, E., Nandakumar, D., Lari, A., Ly, M., Tucker, J. M., & Glaunsinger, B. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.013930 · Cited by 544

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV

Liu, W. J., Zhao, M. J., Liu, K., Xu, K., Wong, G., Tan, W., & Gao, G. F. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.006 · Cited by 400

Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China

Chen, R., Sang, L., Jiang, M., Yang, Z., Jia, N., Fu, W., Xie, J., Guan, W., Liang, W., Ni, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.003 · Cited by 380

Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus

Zhou, J., Li, C., Zhao, G., Chu, H., Wang, D., Yan, H. H.-N., Poon, V. K., Wen, L., Wong, B. H., Zhao, X., et al. (2017) · Science Advances · doi:10.1126/sciadv.aao4966 · Cited by 376

Effective inhibition of MERS-CoV infection by resveratrol

Lin, S., Ho, C., Chuo, W., Li, S., Wang, T. T., & Lin, C. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2253-8 · Cited by 357

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection

Liang, Y., Wang, M., Chien, C., Yarmishyn, A. A., Yang, Y.-P., Lai, W.-Y., Luo, Y., Lin, Y.-T., Chen, Y.-J., Chang, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01022 · Cited by 347

Lessons for COVID-19 immunity from other coronavirus infections

Sariol, A., & Perlman, S. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.005 · Cited by 317

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Rodríguez, Y., Novelli, L., Rojas, M., Santis, M. D., Acosta‐Ampudia, Y., Monsalve, D. M., Ramírez-Santana, C., Costanzo, A., Ridgway, W. M., Ansari, A. A., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102506 · Cited by 319

From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses

Kirtipal, N., Bharadwaj, S., & Kang, S. G. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104502 · Cited by 339

Overview of lethal human coronaviruses

Chen, B., Tian, E.-K., He, B., Tian, L., Han, R., Wang, S., Xiang, Q., Zhang, S., Arnaout, T. E., & Cheng, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0190-2 · Cited by 309

Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus

Fehr, A. R., Channappanavar, R., & Perlman, S. M. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-051215-031152 · Cited by 299

Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication

Yan, B., Chu, H., Yang, D., Sze, K. H., Lai, P.-M., Yuan, S., Shuai, H., Wang, Y., Kao, R. Y. T., Chan, J. F., et al. (2019) · Viruses · doi:10.3390/v11010073 · Cited by 267

Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses

Zhao, J., Alshukairi, A. N., Baharoon, S. A., Ahmed, W., Bokhari, A. A., Nehdi, A., Layqah, L. A., Alghamdi, M., Algethamy, M., Dada, A. M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan5393 · Cited by 262

SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target

Yuan, S., Chu, H., Chan, J. F., Ye, Z., Wen, L., Yan, B., Lai, P.-M., Tee, K., Huang, J., Chen, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08015-x · Cited by 253

Laboratory abnormalities in children with novel coronavirus disease 2019

Henry, B. M., Lippi, G., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0272 · Cited by 252

Chemokines and chemokine receptors during COVID-19 infection

Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.034 · Cited by 248

The clinical course and its correlated immune status in COVID-19 pneumonia

He, R., Lu, Z., Zhang, L., Fan, T. T., Xiong, R., Shen, X., Feng, H., Meng, H., Lin, W., Jiang, W., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104361 · Cited by 235

Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus

Yong, C. Y., Ong, H. K., Yeap, S. K., Ho, K. L., & Tan, W. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01781 · Cited by 224

Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression

Schönrich, G., Raftery, M. J., & Samstag, Y. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100741 · Cited by 226

An overview on the seven pathogenic human coronaviruses

Kesheh, M. M., Hosseini, P., Soltani, S., & Zandi, M. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2282 · Cited by 212

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection

Synowiec, A., Szczepański, A., Barreto-Durán, E., Lie, L. K., & Pyrć, K. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-20 · Cited by 228

The Immune Response and Immunopathology of COVID-19

Mortaz, E., Tabarsi, P., Varahram, M., Folkerts, G., & Adcock, I. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02037 · Cited by 210

Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines

Lee, S., Channappanavar, R., & Kanneganti, T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.005 · Cited by 206

Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2

Su, C.-M., Wang, L., & Yoo, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-92941-2 · Cited by 210

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development

Mubarak, A., Alturaiki, W., & Hemida, M. G. (2019) · Journal of Immunology Research · doi:10.1155/2019/6491738 · Cited by 201

Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, ChinaPreprint

Cao, M., Zhang, D., Wang, Y., Lu, Y., Zhu, X., Li, Y., Xue, H., Lin, Y.-X., Zhang, M., Sun, Y., et al. (2020) · medRxiv · doi:10.1101/2020.03.04.20030395 · Cited by 199

Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4 -transgenic mice infected with MERS-CoV

Jiang, Y., Zhao, G., Song, N., Li, P., Chen, Y., Guo, Y., Li, J., Du, L., Jiang, S., Guo, R., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0063-8 · Cited by 195

MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape

Menachery, V. D., Schäfer, A., Burnum-Johnson, K., Mitchell, H. D., Eisfeld, A. J., Walters, K., Nicora, C., Purvine, S. O., Casey, C., Monroe, M. E., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706928115 · Cited by 193

Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells

Chu, H., Chan, C.-M., Zhang, X., Wang, Y., Yuan, S., Zhou, J., Au-Yeung, R. K. H., Sze, K. H., Yang, D., Shuai, H., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001897 · Cited by 188

Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract

Meyerholz, D. K., Lambertz, A. M., & McCray, P. B. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.09.014 · Cited by 181

Attenuated Interferon and Proinflammatory Response in SARS-CoV-2–Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation

Yang, D., Chu, H., Hou, Y., Chai, Y., Shuai, H., Lee, A. C.-Y., Zhang, X., Wang, Y., Hu, B., Huang, X., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa356 · Cited by 179

MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2

Yeung, M. L., Yao, Y., Jia, L., Chan, J. F., Chan, K., Cheung, K.-F., Chen, H., Poon, V. K., Tsang, A. K. L., To, K. K., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.4 · Cited by 175

Animal and translational models of SARS-CoV-2 infection and COVID-19

Johansen, M. D., Irving, A. T., Montagutelli, X., Tate, M. D., Rudloff, I., Nold, M. F., Hansbro, N. G., Kim, R., Donovan, C., Liu, G., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00340-z · Cited by 173

ACE2-independent infection of T lymphocytes by SARS-CoV-2

Shen, X.-R., Geng, R., Li, Q., Chen, Y., Li, S., Wang, Q. M., Min, J., Yang, Y. P., Li, B., Jiang, R.-D., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00919-x · Cited by 175

Scoring Systems for Predicting Mortality for Severe Patients with COVID-19

Shang, Y., Liu, T., Wei, Y., Li, J., Shao, L., Liu, M., Zhang, Y., Zhao, Z., Xu, H., Peng, Z., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100426 · Cited by 172

Modeling the viral dynamics of SARS-CoV-2 infection

Wang, S., Pan, Y., Wang, Q., Miao, H., Brown, A. N., & Rong, L. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108438 · Cited by 173

Changes of hematological and immunological parameters in COVID-19 patients

Yuan, X., Huang, W., Ye, B., Chen, C., Huang, R., Wu, F., Qin, W., Zhang, W., & Hu, J. (2020) · International Journal of Hematology · doi:10.1007/s12185-020-02930-w · Cited by 171

Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?

Musa, S. (2020) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2020.03.002 · Cited by 170

Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration

Chen, R., Lan, Z., Ye, J., Pang, L., Liu, Y., Wu, W., Qin, X., Guo, Y., & Zhang, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.589095 · Cited by 165

Molecular Basis of Coronavirus Virulence and Vaccine Development

Enjuanes, L., Zúñiga, S., Castaño-Rodríguez, C., Gutierrez-Alvarez, F. J., Cantón, J., & Sola, I. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.003 · Cited by 165

Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19

Huang, J., Song, W., Huang, H., & Sun, Q. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041131 · Cited by 165

Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients

Yao, Q., Wang, P., Wang, X., Qie, G., Meng, M., Tong, X., Bai, X., Ding, M., Liu, W., Keke, L., et al. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15312 · Cited by 152

Immune responses during COVID-19 infection

Melenotte, C., Silvin, A., Goubet, A., Lahmar, I., Dubuisson, A., Zumla, A. I., Raoult, D., Merad-Boudia, M., Gachot, B., Henon, C., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1807836 · Cited by 167

Infectability of Human BrainSphere Neurons Suggests Neurotropism of SARS-CoV-2*

Bullen, C. K. (2020) · ALTEX · doi:10.14573/altex.2006111 · Cited by 147

Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms

Jafarzadeh, A., Jafarzadeh, S., Nozari, P., Mokhtari, P., & Nemati, M. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12967 · Cited by 155

Host and viral determinants for efficient SARS-CoV-2 infection of the human lung

Chu, H., Hu, B., Huang, X., Chai, Y., Zhou, D., Wang, Y., Shuai, H., Yang, D., Hou, Y., Zhang, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20457-w · Cited by 141

SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients

Pontelli, M. C., Castro, Í. A., Júnior, R. B. M., Serra, L. L., Veras, F. P., Nascimento, D. C., Silva, C. M. S., Cardoso, R. D. S., Rosales, R., Gomes, R., et al. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac021 · Cited by 141

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy

Jiang, Y.-Z., Rubin, L., Peng, T., Liu, L., Xing, X., Lazarovici, P., & Zheng, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59272 · Cited by 144

Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients

Ko, J., Park, G. E., Lee, J. Y., Lee, J., Cho, S. Y., Ha, Y. E., Kang, C., Kang, J., Kim, Y., Huh, H. J., et al. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.08.005 · Cited by 138

COVID-19 and the role of cytokines in this disease

Hasanvand, A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00992-2 · Cited by 138

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies

Ricke, D. O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640093 · Cited by 133

ACE2: the molecular doorway to SARS-CoV-2

Medina-Enríquez, M. M., López‐León, S., Carlos-Escalante, J. A., Torres, Z. A., Cuapio, A., & Wegman-Ostrosky, T. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00519-8 · Cited by 136

High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia

Alshukairi, A. N., Zheng, J. H., Zhao, J., Nehdi, A., Baharoon, S. A., Layqah, L. A., Bokhari, A. A., Johani, S. M. A., Samman, N., Boudjelal, M., et al. (2018) · mBio · doi:10.1128/mbio.01985-18 · Cited by 136

A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis

Chen, L., Hu, C., Hood, M. M., Zhang, X., Zhang, L., Kan, J., & Du, J. C. (2020) · Nutrients · doi:10.3390/nu12041193 · Cited by 132

The immuno-oncological challenge of COVID-19

Derosa, L., Melenotte, C., Griscelli, F., Gachot, B., Marabelle, A., Kroemer, G., & Zitvogel, L. (2020) · Nature Cancer · doi:10.1038/s43018-020-00122-3 · Cited by 136

Lymphopenia Caused by Virus Infections and the Mechanisms Beyond

Guo, Z., Zhang, Z., Prajapati, M., & Li, Y. (2021) · Viruses · doi:10.3390/v13091876 · Cited by 141

Clinical Characteristics of Children With COVID-19: A Meta-Analysis

Ding, Y., Yan, H., & Guo, W. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00431 · Cited by 136

Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2

Banerjee, A., Nasir, J. A., Budylowski, P., Yip, L., Aftanas, P., Christie, N., Ghalami, A., Baid, K., Raphenya, A. R., Hirota, J. A., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2609.201495 · Cited by 126

MERS coronavirus outbreak: Implications for emerging viral infections

Al‐Omari, A., Rabaan, A. A., Salih, S., Al‐Tawfiq, J. A., & Memish, Z. A. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.011 · Cited by 123

MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract

Alosaimi, B., Hamed, M. E., Naeem, A., Alsharef, A. A., Alqahtani, S. Y., Aldosari, K., Alamri, A. A., Al-Eisa, K., Khojah, T., Assiri, A. M., et al. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154895 · Cited by 116

Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction

Wang, J., Yang, X., Li, Y., Huang, J., Jiang, J., & Su, N. (2021) · Virology Journal · doi:10.1186/s12985-021-01588-y · Cited by 113

Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients

Yang, Z., Shi, J. H., He, Z., Lü, Y., Xu, Q., Ye, C., Chen, S., Tang, B., Yin, K., Lu, Y., et al. (2020) · Aging · doi:10.18632/aging.102999 · Cited by 109

Abnormal immunity of non-survivors with COVID-19: predictors for mortality

Zhao, Y., Nie, H., Hu, K., Wu, X., Zhang, Y., Wang, M. E., Wang, T., Zheng, Z., Li, X., & Zeng, S. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00723-1 · Cited by 107

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study

Zheng, Y., Zhang, Y., Chi, H., Chen, S., Peng, M., Lifei, L., Chen, L., Li, J., Shen, B., & Wang, D. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0377 · Cited by 105

COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms

Ostaszewski, M., Niarakis, A., Mazein, A., Kuperstein, I., Phair, R. D., Resendiz, A. O., Singh, V., Aghamiri, S. S., Acencio, M. L., Glaab, E., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110387 · Cited by 104

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections

Zhang, Y.-Y., Li, B.-R., & Ning, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02033 · Cited by 103

SARS coronavirus 2: from genome to infectome

Rastogi, M., Pandey, N., Shukla, A., & Singh, S. K. (2020) · Respiratory Research · doi:10.1186/s12931-020-01581-z · Cited by 107

Advances in gene-based vaccine platforms to address the COVID-19 pandemic

Pushparajah, D., Jimenez, S., Wong, S. L., Alattas, H., Nafissi, N., & Slavcev, R. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.003 · Cited by 99

Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections

Skariyachan, S., Challapilli, S. B., Packirisamy, S., Kumargowda, S. T., & Sridhar, V. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00569 · Cited by 99

Clinical characteristics of 34 COVID-19 patients admitted to intensive care unit in Hangzhou, China

Zheng, Y. F., Sun, L., Xu, M., Pan, J., Zhang, Y., Fang, X., Fang, Q., & Cai, H. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000174 · Cited by 96

Pregnancy and COVID-19: management and challenges

Wenling, Y., Qiu, J., Xiao, Z., & Ouyang, S. (2020) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202062062 · Cited by 103

Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients

Lavillegrand, J., Garnier, M., Spaeth, A., Mario, N., Hariri, G., Pilon, A., Berti, E., Fieux, F., Thietart, S., Urbina, T., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-020-00798-x · Cited by 98

SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs

Xiang, Q., Feng, Z., Diao, B., Tu, C., Qiao, Q., Yang, H., Zhang, Y., Wang, G., Wang, H., Wang, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661052 · Cited by 96

Risk factors related to hepatic injury in patients with corona virus disease 2019Preprint

Lu, L., Li, S., Xu, M., Yu, P., Zheng, S., Duan, Z., Liu, J., Chen, Y., & Li, J. (2020) · medRxiv · doi:10.1101/2020.02.28.20028514 · Cited by 98

Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis

Zhou, J., Chu, H., Chan, J. F., & Yuen, K. (2015) · Virology Journal · doi:10.1186/s12985-015-0446-6 · Cited by 86

Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus

Ying, T., Li, W., & Dimitrov, D. S. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv381 · Cited by 42

REVIEW Open Access Middle East respiratory syndrome

(2016)

Massive Infektion und alveolare Schädigung der humanen Lunge durch das Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Becher, A., von Recum, J., Schierhorn, K. L., Wolff, T., Tönnies, M., Neudecker, J., Rückert, J. C., Schneider, P., Gruber, A., Suttorp, N., et al. (2015) · Pneumologie · doi:10.1055/s-0035-1548632

CD8 + T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome

Coleman, C. M., Sisk, J. M., Halász, G., Zhong, J., Beck, S. E., Matthews, K. L., Venkataraman, T., Rajagopalan, S., Kyratsous, C. A., & Frieman, M. B. (2016) · Journal of Virology · doi:10.1128/jvi.01825-16 · Cited by 65